Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  DBV Technologies    DBV   FR0010417345

DBV TECHNOLOGIES

(DBV)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

European ADRs Move Sharply Lower in Friday Trading

01/15/2021 | 11:09am EST


ę MT Newswires 2021
All news about DBV TECHNOLOGIES
03/01DBV Technologies to Report Full Year 2020 Financial Results on March 4, 2021
GL
02/24DBV TECHNOLOGIESá : to Participate in Upcoming AAAAI 2021 Congress
GL
02/22DBV TECHNOLOGIESá : Names Chief Legal Officer
MT
02/22DBV TECHNOLOGIESá : Announces Appointment of Michele F. Robertson as Chief Legal..
GL
02/19DBV TECHNOLOGIESá : to Participate in SVB Leerink Global Partners Healthcare Con..
AQ
02/12European ADRs Move Higher in Friday Trading
MT
02/11European ADRs Nudge Higher in Thursday Trading
MT
02/01European ADRs Move Higher in Monday Trading
MT
02/01DBV TECHNOLOGIESá : - Half-Year Report on the DBV Technologiesá: Liquidity Contr..
AQ
01/31DBV TECHNOLOGIESá : Monthly statement on outstanding equity shares and voting ri..
CO
More news
Financials
Sales 2020 14,8 M 17,7 M 17,7 M
Net income 2020 -166 M -199 M -199 M
Net cash 2020 124 M 149 M 149 M
P/E ratio 2020 -2,33x
Yield 2020 -
Capitalization 496 M 598 M 596 M
EV / Sales 2020 25,2x
EV / Sales 2021 23,6x
Nbr of Employees 311
Free-Float 92,1%
Chart DBV TECHNOLOGIES
Duration : Period :
DBV Technologies Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DBV TECHNOLOGIES
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 4
Average target price 8,15 €
Last Close Price 9,04 €
Spread / Highest target 21,7%
Spread / Average Target -9,85%
Spread / Lowest Target -36,9%
EPS Revisions
Managers and Directors
NameTitle
Daniel TassÚ Chief Executive Officer & Executive Director
SÚbastien Robitaille Chief Financial Officer
Michel de Rosen Non-Executive Chairman
Bertrand Dupont Chief Technology Officer
Pharis Mohideen Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
DBV TECHNOLOGIES108.49%598
CSL LIMITED-4.56%92 178
WUXI BIOLOGICS (CAYMAN) INC.-0.49%52 131
SAMSUNG BIOLOGICS CO.,LTD.-9.20%43 986
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.25.76%43 127
BIOGEN INC.11.44%41 569